Brief: Blue Vision H1 Result Turns To Profit At SEK 1.8 Mln
Aug 31 (Reuters) - Blue Vision A/S BLVISa.CO :
* AS A RESULT OF COMPANY'S SPECIAL CIRCUMSTANCES, PROFIT
TARGETS
FOR 2022 WILL NOT BE ANNOUNCED
* PROFIT AFTER TAX AMOUNTS TO SEK 1,792 THOUSAND. FOR THE
PERIOD 1
JANUARY – 30 JUNE 2022 (1 JANUARY – 30 JUNE 2021: SEK -667,000)
* H1 PRE-TAX PROFIT DKK 1.8 MILLION VERSUS LOSS DKK 0.7
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE2TkHq5
Further company coverage: BLVISa.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations